Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

Bullboard Posts

Comment by KingWhatsion Nov 09, 2010 3:22pm

395 Views

Post# 17682240

RE: RE: Do I see a Cup

If anyone had been paying attention, the chart indicators were all off the wall. We needed this little correction. I thought it was settling down last week but not quite. We are leveling off now. Someone here recently said "ugly chart". They are obviously technically challenged.

The stock was way over sold which tells me the mm's had shorted heavily on that last spike and now they're covering for a nice profit. Hopefully not on the backs of any members of this friendly group.

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading